These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2420016)

  • 21. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
    Kalamaras A; Chassanidis C; Samara M; Papadakis MN; Vagena A; Aleporou-Marinou V; Patrinos GP; Kollia P
    Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
    Haematologica; 2008 Oct; 93(10):1584-6. PubMed ID: 18728025
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterogeneity of fetal hemoglobin among Israel families with beta-thalassemia.
    Rachmilewitz EA; Huisman TH; Schroeder WA
    Isr J Med Sci; 1973; 9(9):1464-8. PubMed ID: 4775133
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of intermediate thalassemia].
    Cacciola E
    Haematologica; 1989 Oct; 74(5 Suppl):252-65. PubMed ID: 2480271
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythrocyte ferritin in thalassemia syndromes.
    Piperno A; Taddei MT; Sampietro M; Fargion S; Arosio P; Fiorelli G
    Acta Haematol; 1984; 71(4):251-6. PubMed ID: 6426238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of red blood cell indices, hemoglobin A2, and hemoglobin F in infants heterozygous for Beta-thalassemia.
    Galanello R; Melis MA; Ruggeri R; Cao A
    J Pediatr; 1981 Jul; 99(1):105-8. PubMed ID: 6166735
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of erythrocyte ferritin in heterozygous A2 and F thalassemias].
    Mira Y; Llopis R; Cubillo P; Laiz B; Vaya A; Aznar J
    Sangre (Barc); 1987; 32(4):460-4. PubMed ID: 3660184
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thalassemia intermedia. Report of two cases].
    Khaldi F; Hassine F; Guemira F; Bennaceur B; Fattoum S
    Ann Pediatr (Paris); 1990 Sep; 37(7):455-7. PubMed ID: 1701619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic changes and hemoglobin analysis beta thalassemia heterozygotes during the first year of life.
    Wood WG; Weatherall DJ; Hart GH; Bennett M; Marsh GW
    Pediatr Res; 1982 Apr; 16(4 Pt 1):286-9. PubMed ID: 6176934
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular basis and hematologic characterization of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin in Thailand.
    Panyasai S; Fucharoen S; Surapot S; Fucharoen G; Sanchaisuriya K
    Haematologica; 2004 Jul; 89(7):777-81. PubMed ID: 15257928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemoglobin E-beta-thalassaemia; a study of eight cases in Northwest India.
    Ghosh K; Chakrabarty AK; Mohanty D; Das KC
    Trop Geogr Med; 1983 Sep; 35(3):267-71. PubMed ID: 6196886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mass screening for microcythemia].
    Alberti R
    Minerva Med; 1983 Dec; 74(49-50):2909-14. PubMed ID: 6198606
    [No Abstract]   [Full Text] [Related]  

  • 35. The laboratory evaluation of microcytic red blood cells.
    Marsh WL; Koenig HM
    Crit Rev Clin Lab Sci; 1982; 16(3):195-254. PubMed ID: 6178550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of iron overload in thalassemia].
    Piga A; Davico S; Magliano M; Luzzatto L; Sandri A; Gabutti V
    Pediatr Med Chir; 1986; 8(1):9-13. PubMed ID: 3725619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-thalassaemia in Cuba.
    de la Torre E; Hernandez P; Martinez G; Srarch E; Colombo B
    Haematologia (Budap); 1974; 8(1-4):71-9. PubMed ID: 4461439
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 40. A non-deletion hereditary persistence of fetal hemoglobin (HPFH) determinant not linked to the beta-globin gene complex.
    Thein SL; Weatherall DJ
    Prog Clin Biol Res; 1989; 316B():97-111. PubMed ID: 2482508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.